The acetyltransferase p300 was first identified associated with the adenovi
ral transforming protein E1A, suggesting a potential role for p300 in the r
egulation of cell proliferation. Direct evidence demonstrating a role for p
300 in human tumours was lacking until the recently publication by Gayther
et al, which strongly supports a role for p300 as a tumour suppressor. The
authors identify truncating mutations associated with the loss or mutation
of the second allele in both tumour samples and cell lines, suggesting that
loss of p300 may play a role in the development of a subset of human cance
rs.